Does Health-Related Quality of Life Improve for Advanced Pancreas Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

CONTEXT: Gemcitabine for advanced pancreas cancer (APC) is palliative and prognosis is poor, making health-related quality of life (HRQOL) particularly important. OBJECTIVES: We evaluated HRQOL with the EuroQol EQ-5D™, in patients with APC participating in Cancer and Leukemia Group B (CALGB) 80303,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Romanus, Dorothy, Kindler, Hedy L., Archer, Laura, Basch, Ethan, Niedzwiecki, Donna, Weeks, Jane, Schrag, Deborah
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3658140/
https://ncbi.nlm.nih.gov/pubmed/22104618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpainsymman.2011.09.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky